Clinical trials recruiting for NSCLC (Non-small Cell Lung Carcinoma)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cisplatin, Carboplatin, Pemetrexed, Gemcitabine, Paclitaxel, Docetaxel | 1 |
| Definitive Thoracic Radiotherapy | 1 |
| Docetaxel | 1 |
| Firmonertinib | 1 |
| Nivolumab 40mg | 1 |
| daraxonrasib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| California | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Michigan | 1 |
| Missouri | 1 |
| Montana | 1 |
Top cities
Self-screener
Recruiting trials
- Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
- Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC
- Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Related conditions
Trials recruiting for NSCLC (Non-small Cell Lung Carcinoma) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for NSCLC (Non-small Cell Lung Carcinoma) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.